• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朝着精准减肥饮食干预迈进:POUNDS LOST 试验的结果。

Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial.

机构信息

Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70118, USA.

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

出版信息

Nutrients. 2023 Aug 21;15(16):3665. doi: 10.3390/nu15163665.

DOI:10.3390/nu15163665
PMID:37630855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10458797/
Abstract

The POUNDS Lost trial is a 2-year clinical trial testing the effects of dietary interventions on weight loss. This study included 811 adults with overweight or obesity who were randomized to one of four diets that contained either 15% or 25% protein and 20% or 40% fat in a 2 × 2 factorial design. By 2 years, participants on average lost from 2.9 to 3.6 kg in body weight in the four intervention arms, while no significant difference was observed across the intervention arms. In POUNDS Lost, we performed a series of ancillary studies to detect intrinsic factors particular to genomic, epigenomic, and metabolomic markers that may modulate changes in weight and other cardiometabolic traits in response to the weight-loss dietary interventions. Genomic variants identified from genome-wide association studies (GWASs) on obesity, type 2 diabetes, glucose and lipid metabolisms, gut microbiome, and dietary intakes have been found to interact with dietary macronutrients (fat, protein, and carbohydrates) in relation to weight loss and changes of body composition and cardiometabolic traits. In addition, we recently investigated epigenomic modifications, particularly blood DNA methylation and circulating microRNAs (miRNAs). We reported DNA methylation levels at , , , and were related to weight loss or changes of glucose, lipids, and blood pressure; we also reported thrifty miRNA expression as a significant epigenomic marker related to changes in insulin sensitivity and adiposity. Our studies have also highlighted the importance of temporal changes in novel metabolomic signatures for gut microbiota, bile acids, and amino acids as predictors for achievement of successful weight loss outcomes. Moreover, our studies indicate that biochemical, behavioral, and psychosocial factors such as physical activity, sleep disturbance, and appetite may also modulate metabolic changes during dietary interventions. This review summarized our major findings in the POUNDS Lost trial, which provided preliminary evidence supporting the development of precision diet interventions for obesity management.

摘要

POUNDS Lost 试验是一项为期 2 年的临床试验,旨在测试饮食干预对减肥的影响。该研究纳入了 811 名超重或肥胖成年人,他们被随机分配到四种饮食组之一,这四种饮食组的蛋白质含量分别为 15%或 25%,脂肪含量分别为 20%或 40%,采用 2×2 析因设计。到 2 年时,四组干预组参与者的体重平均减轻了 2.9 至 3.6 公斤,而四组干预之间没有观察到显著差异。在 POUNDS Lost 试验中,我们进行了一系列辅助研究,以检测特定于基因组、表观基因组和代谢组学标记的内在因素,这些因素可能调节体重和其他心血管代谢特征对减肥饮食干预的变化。从肥胖、2 型糖尿病、葡萄糖和脂质代谢、肠道微生物组和饮食摄入的全基因组关联研究(GWAS)中确定的基因组变异已被发现与饮食中的宏量营养素(脂肪、蛋白质和碳水化合物)相互作用,与减肥以及身体成分和心血管代谢特征的变化有关。此外,我们最近研究了表观基因组修饰,特别是血液 DNA 甲基化和循环 microRNAs(miRNAs)。我们报告了与体重减轻或葡萄糖、脂质和血压变化相关的、、和 处的 DNA 甲基化水平;我们还报告了节俭的 miRNA 表达作为与胰岛素敏感性和肥胖变化相关的重要表观基因组标记。我们的研究还强调了肠道微生物群、胆汁酸和氨基酸的新型代谢组学特征的时间变化作为成功减肥结果预测指标的重要性。此外,我们的研究表明,生化、行为和心理社会因素,如体力活动、睡眠障碍和食欲,也可能调节饮食干预期间的代谢变化。本综述总结了我们在 POUNDS Lost 试验中的主要发现,这些发现为肥胖管理的精准饮食干预提供了初步证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/fd80d9ffa838/nutrients-15-03665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/ccf19f2aa25b/nutrients-15-03665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/36d5a5d50b2b/nutrients-15-03665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/c78d6ce07ed1/nutrients-15-03665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/fd80d9ffa838/nutrients-15-03665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/ccf19f2aa25b/nutrients-15-03665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/36d5a5d50b2b/nutrients-15-03665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/c78d6ce07ed1/nutrients-15-03665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9c/10458797/fd80d9ffa838/nutrients-15-03665-g004.jpg

相似文献

1
Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial.朝着精准减肥饮食干预迈进:POUNDS LOST 试验的结果。
Nutrients. 2023 Aug 21;15(16):3665. doi: 10.3390/nu15163665.
2
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
3
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
4
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
5
Interventions to prevent obesity in children aged 2 to 4 years old.预防2至4岁儿童肥胖的干预措施。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015326. doi: 10.1002/14651858.CD015326.pub2.
6
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
7
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.肥胖治疗的长期效果、经济后果及其对健康改善影响的系统评价
Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210.
8
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
9
Effects of total fat intake on bodyweight in children.儿童总脂肪摄入量对体重的影响。
Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD012960. doi: 10.1002/14651858.CD012960.pub2.
10
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.

引用本文的文献

1
Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study.成人超重和肥胖的流行病学概况及影响:IMPACT-O研究的多国结果
Adv Ther. 2025 Aug 19. doi: 10.1007/s12325-025-03333-1.
2
Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment.高效抗肥胖治疗时代的肥胖生活方式医学
Nutrients. 2025 Jul 21;17(14):2382. doi: 10.3390/nu17142382.
3
Using Metabolic Testing to Personalize Behavioral Obesity Treatment.利用代谢测试实现行为性肥胖治疗的个性化。

本文引用的文献

1
DNA Methylation of Birthweight-Blood Pressure Genes and Changes of Blood Pressure in Response to Weight-Loss Diets in the POUNDS Lost Trial.体重减轻试验中出生体重-血压基因的 DNA 甲基化与血压对减肥饮食的反应变化。
Hypertension. 2023 Jun;80(6):1223-1230. doi: 10.1161/HYPERTENSIONAHA.123.20864. Epub 2023 Apr 11.
2
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective.心脏代谢健康、饮食与肠道微生物组:宏基因组学视角
Nat Med. 2023 Mar;29(3):551-561. doi: 10.1038/s41591-023-02260-4. Epub 2023 Mar 17.
3
DNA Methylation Near CPT1A and Changes in Triglyceride-rich Lipoproteins in Response to Weight-loss Diet Interventions.
Obes Sci Pract. 2025 Mar 11;11(2):e70065. doi: 10.1002/osp4.70065. eCollection 2025 Apr.
4
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
5
Exploring Opportunities to Better Characterize the Effects of Dietary Protein on Health across the Lifespan.探索更好地描述膳食蛋白质在整个生命周期对健康影响的机会。
Adv Nutr. 2025 Jan;16(1):100347. doi: 10.1016/j.advnut.2024.100347. Epub 2024 Nov 26.
6
Continental differences in the association between excess body weight and prognosis in triple-negative breast cancer: a meta-analysis.三阴性乳腺癌中超重与预后之间关联的大陆差异:一项荟萃分析。
Breast Cancer Res Treat. 2025 Jan;209(2):215-227. doi: 10.1007/s10549-024-07538-w. Epub 2024 Oct 30.
7
Is There an Ideal Diet? Some Insights from the POUNDS Lost Study.是否存在理想的饮食?POUNDS Lost 研究的一些见解。
Nutrients. 2024 Jul 20;16(14):2358. doi: 10.3390/nu16142358.
8
Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial.胆汁酸亚型的变化以及脂质代谢和动脉粥样硬化性心血管疾病风险的改善:使用新型饮食策略预防超重(POUNDS Lost)试验
Am J Clin Nutr. 2024 May;119(5):1293-1300. doi: 10.1016/j.ajcnut.2024.02.019. Epub 2024 Feb 28.
9
Grain Intake and Cardiometabolic Health-Towards Precision Nutrition.谷物摄入量与心脏代谢健康——迈向精准营养。
Nutrients. 2023 Oct 30;15(21):4605. doi: 10.3390/nu15214605.
CPT1A 附近的 DNA 甲基化与体重减轻饮食干预后富含甘油三酯的脂蛋白的变化。
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e542-e549. doi: 10.1210/clinem/dgad086.
4
Circulating thrifty microRNA is related to insulin sensitivity, adiposity, and energy metabolism in adults with overweight and obesity: the POUNDS Lost trial.循环节俭型 microRNA 与超重和肥胖成年人的胰岛素敏感性、肥胖和能量代谢有关:POUNDS Lost 试验。
Am J Clin Nutr. 2023 Jan;117(1):121-129. doi: 10.1016/j.ajcnut.2022.10.001. Epub 2022 Dec 15.
5
Genetically determined gut microbial abundance and 2-year changes in central adiposity and body composition: The POUNDS lost trial.遗传决定的肠道微生物丰度与中心性肥胖和身体成分的 2 年变化:POUNDS LOST 试验。
Clin Nutr. 2022 Dec;41(12):2817-2824. doi: 10.1016/j.clnu.2022.11.002. Epub 2022 Nov 5.
6
Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial.体重减轻饮食引起的循环胆汁酸亚型的变化与血糖状态和胰岛素抵抗的改善相关:POUNDS LOST 试验。
Metabolism. 2022 Nov;136:155312. doi: 10.1016/j.metabol.2022.155312. Epub 2022 Sep 16.
7
Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review.多基因风险评分在冠心病一级预防中的增量价值:综述。
JAMA Intern Med. 2022 Oct 1;182(10):1082-1088. doi: 10.1001/jamainternmed.2022.3171.
8
Nutrition for precision health: The time is now.精准健康营养:时不我待。
Obesity (Silver Spring). 2022 Jul;30(7):1335-1344. doi: 10.1002/oby.23448.
9
Large-scale GWAS of food liking reveals genetic determinants and genetic correlations with distinct neurophysiological traits.大规模全基因组关联研究揭示了食物偏好的遗传决定因素以及与不同神经生理特征的遗传相关性。
Nat Commun. 2022 May 18;13(1):2743. doi: 10.1038/s41467-022-30187-w.
10
Epigenetics in Precision Nutrition.精准营养中的表观遗传学
J Pers Med. 2022 Mar 28;12(4):533. doi: 10.3390/jpm12040533.